BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 16294265)

  • 1. Critical role of beta3 integrin in experimental postmenopausal osteoporosis.
    Zhao H; Kitaura H; Sands MS; Ross FP; Teitelbaum SL; Novack DV
    J Bone Miner Res; 2005 Dec; 20(12):2116-23. PubMed ID: 16294265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential β3 and β1 Integrin Expression in Bone Marrow and Cortical Bone of Estrogen Deficient Rats.
    Voisin M; McNamara LM
    Anat Rec (Hoboken); 2015 Sep; 298(9):1548-59. PubMed ID: 25974241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties.
    Chu K; Snyder R; Econs MJ
    J Bone Miner Res; 2006 Jul; 21(7):1089-97. PubMed ID: 16813529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1.
    Sankar U; Patel K; Rosol TJ; Ostrowski MC
    J Bone Miner Res; 2004 Aug; 19(8):1339-48. PubMed ID: 15231022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice.
    Sun D; Krishnan A; Zaman K; Lawrence R; Bhattacharya A; Fernandes G
    J Bone Miner Res; 2003 Jul; 18(7):1206-16. PubMed ID: 12854830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
    Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ
    J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assembled RANK induces osteoclastogenesis ligand-independently.
    Kanazawa K; Kudo A
    J Bone Miner Res; 2005 Nov; 20(11):2053-60. PubMed ID: 16234979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited rescue of osteoclast-poor osteopetrosis after successful engraftment by cord blood from an unrelated donor.
    Nicholls BM; Bredius RG; Hamdy NA; Gerritsen EJ; Lankester AC; Hogendoorn PC; Nesbitt SA; Horton MA; Flanagan AM
    J Bone Miner Res; 2005 Dec; 20(12):2264-70. PubMed ID: 16294279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin ligand regulates osteoclast adherence to the bone surface in mouse calvaria.
    O'Brien EA; Williams JH; Marshall MJ
    Biochem Biophys Res Commun; 2000 Aug; 274(2):281-90. PubMed ID: 10913332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain-dependent variations in the response of cancellous bone to ovariectomy in mice.
    Iwaniec UT; Yuan D; Power RA; Wronski TJ
    J Bone Miner Res; 2006 Jul; 21(7):1068-74. PubMed ID: 16813527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice lacking the integrin beta5 subunit have accelerated osteoclast maturation and increased activity in the estrogen-deficient state.
    Lane NE; Yao W; Nakamura MC; Humphrey MB; Kimmel D; Huang X; Sheppard D; Ross FP; Teitelbaum SL
    J Bone Miner Res; 2005 Jan; 20(1):58-66. PubMed ID: 15619670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.
    Yang CR; Wang JH; Hsieh SL; Wang SM; Hsu TL; Lin WW
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S97-107. PubMed ID: 15002040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis.
    Hofkens W; Grevers LC; Walgreen B; de Vries TJ; Leenen PJ; Everts V; Storm G; van den Berg WB; van Lent PL
    J Control Release; 2011 Jun; 152(3):363-9. PubMed ID: 21396411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of sustained ERK activity with integrin beta3 induction during receptor activator of nuclear factor kappaB ligand (RANKL)-directed osteoclast differentiation.
    Kim HH; Chung WJ; Lee SW; Chung PJ; You JW; Kwon HJ; Tanaka S; Lee ZH
    Exp Cell Res; 2003 Oct; 289(2):368-77. PubMed ID: 14499638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation.
    Faccio R; Takeshita S; Zallone A; Ross FP; Teitelbaum SL
    J Clin Invest; 2003 Mar; 111(5):749-58. PubMed ID: 12618529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-7 influences osteoclast function in vivo but is not a critical factor in ovariectomy-induced bone loss.
    Lee SK; Kalinowski JF; Jacquin C; Adams DJ; Gronowicz G; Lorenzo JA
    J Bone Miner Res; 2006 May; 21(5):695-702. PubMed ID: 16734384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver-derived IGF-I is permissive for ovariectomy-induced trabecular bone loss.
    Lindberg MK; Svensson J; Venken K; Chavoshi T; Andersson N; Movérare Skrtic S; Isaksson O; Vanderschueren D; Carlsten H; Ohlsson C
    Bone; 2006 Jan; 38(1):85-92. PubMed ID: 16257281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase.
    Glantschnig H; Fisher JE; Wesolowski G; Rodan GA; Reszka AA
    Cell Death Differ; 2003 Oct; 10(10):1165-77. PubMed ID: 14502240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.